Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2024-01-04 Transaction in Own Shar…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject is a "Transaction in Own Shares" and details the purchase of 200,000 ordinary shares as part of a share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement about RNS confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-01-04 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'Transaction in Own Shares' detailing the purchase of 200,000 ordinary shares as part of a previously announced share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The document includes specific details like the date of purchase, volume, and price, confirming it is a report of the transaction itself, not just an announcement of a report.
2024-01-03 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement (2750 characters) issued via RNS (Regulatory News Service) by Syncona Limited. It explicitly states the 'Total Voting Rights' as of a specific date (31 December 2023) and provides the total number of shares in issue and treasury shares. This information is crucial for shareholders to calculate their notification obligations under the FCA's Disclosure and Transparency Rules (DTR 5.6.1). This type of announcement, which reports a specific regulatory metric (voting rights) and is distributed through an official news service, fits best under the general 'Regulatory Filings' category (RNS) as it is not a comprehensive report (like 10-K or IR) nor does it relate to dividends, management changes, or director dealings. Given the source (RNS Number) and the nature of the content (regulatory disclosure update), RNS is the most appropriate classification.
2024-01-02 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the purchase of 200,000 ordinary shares by the company on December 29, 2023, as part of a previously announced share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company buying back or selling its own shares (share repurchase/issuance). The presence of the RNS Number and the closing statement confirming the information is provided by RNS suggests it is a regulatory announcement, but the specific content dictates the most precise classification is POS.
2024-01-02 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject is a "Transaction in Own Shares" and details the purchase of 200,000 ordinary shares as part of a previously announced share buyback programme. This directly corresponds to the definition of a company buying back or selling its own shares. The filing is made via RNS, but the core content is a Transaction in Own Shares report, which maps to the 'POS' code. The document length is short (3242 chars), but it contains the substantive details of the transaction, not just an announcement that a report is available, making POS more specific than RPA or RNS.
2023-12-29 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of ordinary shares by the company as part of a 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming the information is provided by RNS (the news service of the London Stock Exchange) confirms it is a regulatory announcement, but the specific content dictates the most precise code, which is POS.
2023-12-27 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.